Pharmacogenetic Studies of Paclitaxel in Ovarian Cancer : focus on interindividual differences in pharmacodynamics and pharmacokinetics
Ovarian cancer is one of the most common female cancer diseases in the world today and in Sweden more than 800 new cases are diagnosed every year. The standard treatment consists of chemotherapy with paclitaxel in combination with carboplatin after initial cytoreductive surgery. The response to trea...
Main Author: | Green, Henrik |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Linköpings universitet, Klinisk farmakologi
2007
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-8134 http://nbn-resolving.de/urn:isbn:978-91-85715-84-8 |
Similar Items
-
Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01) -
CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01) -
Therapeutic Drug Monitoring in Psychiatry : Some aspects of utility in clinical practice and research
by: Chermá Yeste, Maria Dolores
Published: (2009) -
Pharmacogenetic Impact on Metabolism and Cytochrome P450 (CYP)3A Inductive Effect of Tamoxifen
by: Mugundu, Ganesh
Published: (2009) -
Pharmacogenetics Approach for the Improvement of COVID-19 Treatment
by: Ingrid Fricke-Galindo, et al.
Published: (2021-03-01)